Dear Daja,

By delivering this special New Year Edition of the OncoWuXi Newsletter, we would like to extend our sincere appreciation for your continued interest in OncoWuXi database, and wish you a happy, healthy and prosperous New Year! This Special Edition will bring you our full-year database overview on target identification and validation, biomarker, targeted oncology, immuno-oncology, and immunology platforms.

It has been our pleasure to collaborate with you throughout the year and with a deep gratitude for your continued trust and support, we look forward to serving you again in 2023!

• CRISPR/Cas9 library-based target ID
• Biochemical & cell-based assays
• 320+ CDX models in mouse
• 50+ Tumor models in rat and hamster
• 40+ Orthotopic models
• 30+ Metastasis models
• 1400+ PDX models
• 90+ Drug-resistant models
• 40+ Autoimmune disease models
• NHP and large animal platform
• 
  

• 80+ Syngeneic models
• 90+ Humanized IO models
• 30+ Immune functional assays
• Multiplex pathology analysis
• Flow-cytometry and full-spectral Flow
• NanoString, scRNAseq and spatial transcriptomics platforms
• CAP Pathology & FACS lab
• 200+ Clinical biomarkers
• GEAM and rare disease models